UnitedHealth Shares Plunge 23% Amid Regulatory Shocks and Weak Guidance

UnitedHealth Group (UNH) shares have experienced a dramatic sell-off, losing 23.1% of their value in less than a month. The stock price plummeted from $356 to $274 as investors reacted to a combination of regulatory headwinds and disappointing outlooks. A primary catalyst for the decline was a Trump administration proposal for a near-flat reimbursement rate increase of just 0.09% for 2027. This proposed rate is significantly lower than industry expectations, raising concerns about future revenue growth in the Medicare space. Furthermore, the company's disappointing financial guidance for 2026 added significant downward pressure on the stock performance. As a heavyweight component of the Dow Jones Industrial Average (DIA), the sharp decline in UNH has broader negative implications for the entire healthcare sector (XLV).